CALCULATE YOUR SIP RETURNS

Shares That Hit Circuit Limits On February 13, 2025, Natco Pharma, P N Gadgil Jewellers, Wockhardt and More

Written by: Dev SethiaUpdated on: Feb 13, 2025, 3:56 PM IST
Indian benchmark indices closed lower today with stocks like Natco Pharma, P N Gadgil Jeweller, and Wockhardt reflecting significant price moves.
Shares That Hit Circuit Limits On February 13, 2025, Natco Pharma, P N Gadgil Jewellers, Wockhardt and More
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On February 13, 2025, BSE Sensex closed 0.04% lower at 76,138.97, while Nifty50 plunged 0.06% to 23,031.40. Amidst the market volatility, stocks like Natco Pharma Ltd, P N Gadgil Jeweller Ltd and Wockhardt Ltd hit circuit limits, reflecting significant price movements. Check out the full list of stocks hitting circuits today.

Stocks That Hit Upper Circuit on February 13, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
Finolex Cables Ltd 1,004.60 13.73 20 78.3 757.9
P N Gadgil Jewellers Ltd 620.8 9.99 10 8.64 51.47
Orient Technologies Ltd 361.4 2.06 5 8.13 29.44
Shakti Pumps (India) Ltd 886.95 3.27 5 3.07 27.22
E2E Networks Ltd 2,138.00 0.4 5 1.18 25

Stocks That Hit Lower Circuit on February 13, 2025

Symbol LTP %chng Price Band % Volume(Lakhs) Value(₹ Crores)
Natco Pharma Ltd 975.05 -20 20 84.08 839.94
Wockhardt Ltd 1,436.50 -5 5 3.08 45.28
Avalon Technologies Ltd 670 -3 5 5.64 38.64
Nibe Ltd 1,275.00 -8.67 10 2.55 32.57
Blue Jet Healthcare Ltd 761.25 -5 5 3.93 30.85

Overview of Companies Hitting Circuits Today

  • Natco Pharma

On February 13, 2025, Natco Pharma share price ended 20% lower at ₹973.35. Natco Pharma’s share price reached a 52-week high of ₹1,638.35, and a 52-week low of ₹849.20 At the current price, Natco Pharma shares are trading at a price-to-earnings (P/E) ratio of 9.84x, based on its trailing 12-month earnings per share (EPS) of ₹98.90, and a price-to-book (P/B) ratio of 2.55, according to exchange data.

  • P N Gadgil Jewellers 

On February 13, 2025, P N Gadgil Jewellers share price ended 10% higher at ₹621.05. P N Gadgil Jewellers’s share price reached a 52-week high of ₹843.80 and a 52-week low of ₹495.25. In Q3 FY25, P N Gadgil reported a 49% increase in consolidated profit, reaching ₹86.03 crore in the latest quarter, compared to ₹57.6 crore a year ago. The company’s revenue from operations rose by 23.5% year-on-year, standing at ₹2,435.75 crore, up from ₹1,972.15 crore in the corresponding period last year.

  • Wockhardt

On February 13, 2025, Wockhardt share price ended 5% lower at ₹1,439.35. Wockhardt share price reached a 52-week high of ₹1,678.60 and a 52-week low of ₹422. At the current price, Wockhardt shares are trading at a price-to-earnings (P/E) ratio of -131.33x, based on its trailing 12-month earnings per share (EPS) of ₹-10.96, and a price-to-book (P/B) ratio of 13.25, according to exchange data.

  • Shakti Pumps (India) Ltd

On February 13, 2025, Shakti Pumps (India) share price ended 1.61% higher at ₹885. Shakti Pumps (India) Ltd’ share price reached a 52-week high of ₹1,398 and a 52-week low of ₹187.21. At the current price, Shakti Pumps (India) Ltd shares are trading at a price-to-earnings (P/E) ratio of 29.07x, based on its trailing 12-month earnings per share (EPS) of ₹29.97, and a price-to-book (P/B) ratio of 12.29, according to exchange data.

  • Blue Jet Healthcare

On February 13, 2025, Blue Jet Healthcare share price ended 5% lower at ₹762.40. Blue Jet Healthcare share price reached a 52-week high of ₹844.85 and a 52-week low of ₹328.95. At the current price, Blue Jet Healthcare shares are trading at a price-to-earnings (P/E) ratio of 56.35x, based on its trailing 12-month earnings per share (EPS) of ₹13.53, and a price-to-book (P/B) ratio of 14.31, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Feb 13, 2025, 3:56 PM IST

Dev Sethia

Dev is a content writer with over 2 years of experience at Business Today, Times of India, and Financial Express. He has also contributed stories in Hindi for BT Bazaar and Khalsa Bandhan News Paper. A journalism postgraduate from ACJ-Bloomberg, Dev enjoys spending his spare time on the cricket pitch.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers